Bio/pharma works hard today to change the calendar to tomorrow.
A complicated vaccination rollout and mixed messages may derail the pandemic endgame
Demand for specific advanced laboratory skills creates a positive employment market.
After a hectic 2020, biopharma looks to deliver on COVID-19 vaccines and move other promising therapies forward.